Empagliflozin inhibits increased Na influx in atrial cardiomyocytes of patients with HFpEF.
Trum M, Riechel J, Schollmeier E, Lebek S, Hegner P, Reuthner K, Heers S, Keller K, Wester M, Klatt S, Hamdani N, Provaznik Z, Schmid C, Maier LS, Arzt M, Wagner S.
Trum M, et al. Among authors: wagner s.
Cardiovasc Res. 2024 May 10:cvae095. doi: 10.1093/cvr/cvae095. Online ahead of print.
Cardiovasc Res. 2024.
PMID: 38728438